Cover Image
Market Research Report

Asia-Pacific PDX Models Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Published by Data Bridge Market Research Private Limited Product code 674770
Published Content info 100 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia-Pacific PDX Models Market: Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
Published: July 1, 2018 Content info: 100 Pages
Description

Asia-Pacific PDX models market is estimated to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

The key market players for Asia-Pacific PDX models market are listed below:

  • Crown Bioscience Inc.
  • The Jackson Laboratory
  • Champion Oncology, Inc.
  • Charles River
  • Oncodesign
  • Wuxi AppTec
  • Horizon Discovery Group plc
  • Pharmatest Services
  • Hera Biolabs
  • EPO Berlin-Buch GmbH
  • Xentech
  • Urolead
  • Creative Animodel
  • EUROPDX
  • MI Bioresearch Inc
  • Aragen Bioscience

The market is further segmented into:

  • Type
  • Tumor Type
  • Application
  • End User

The Asia Pacific PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.

The Asia Pacific PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.

The Asia Pacific PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.

The Asia Pacific PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.

Based on geography, the market is segmented into:

  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Rest of Asia Pacific

Covered in this report

The report covers the present scenario and the growth prospects of the Asia-Pacific PDX models for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION 11

  • 1.1 OBJECTIVES OF THE STUDY 11
  • 1.2 MARKET DEFINITION 11
  • 1.3 OVERVIEW OF ASIA-PACIFIC PDX MODELS MARKET 11
  • 1.4 CURRENCY AND PRICING 12
  • 1.5 LIMITATION 12
  • 1.6 MARKETS COVERED 12

2 MARKET SEGMENTATION 14

  • 2.1 MARKETS COVERED 14
  • 2.2 GEOGRAPHIC SCOPE 15
  • 2.3 YEARS CONSIDERED FOR THE STUDY 15
  • 2.4 CURRENCY AND PRICING 16
  • 2.5 RESEARCH METHODOLOGY 17
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20
  • 2.7 SECONDARY SOURCES 21
  • 2.8 ASSUMPTIONS 21

3 MARKET OVERVIEW 22

  • 3.1 DRIVERS 24
    • 3.1.1 RISING NUMBER OF PHARMACEUTICAL R&D ACTIVITIES IN CANCER RESEARCH 24
    • 3.1.2 PDX MODELS OFFER ADVANTAGES AS COMPARED WITH THE CLASSIC APPROACH 26
    • 3.1.3 RISING NEED FOR PERSONALIZED MEDICINE 27
    • 3.1.4 INCREASING SUPPORT FOR CANCER RESEARCH ACTIVITIES FROM GOVERNMENT AND NON-GOVERNMENT ORGANIZATION 27
  • 3.2 RESTRAINTS 28
    • 3.2.1 HIGH COST OF PDX MODELS 28
    • 3.2.2 STRICT REGULATION WITH RESPECT TO THE UTILIZATION OF ANIMAL MODELS IN CANCER RESEARCH 28
  • 3.3 OPPRTUNITIES 29
    • 3.3.1 INCREASING DEMAND FOR HUMANIZED PDX MODELS 29
  • 3.4 CHALLENGES 30
    • 3.4.1 LIMITATIONS OF PDX MODELS 30

4 EXECUTIVE SUMMARY 31

5 PREMIUM INSIGHTS 33

6 ASIA-PACIFIC PDX MODELS MARKET, BY TYPE 36

  • 6.1 OVERVIEW 37
  • 6.2 MICE MODELS 39
  • 6.3 RAT MODELS 40

7 ASIA-PACIFIC PDX MODELS MARKET, BY TUMOR TYPE 41

  • 7.1 OVERVIEW 42
  • 7.2 GASTROINTESTINAL TUMOR MODELS 44
  • 7.3 GYNECOLOGICAL TUMOR MODELS 45
  • 7.4 RESPIRATORY TUMOR MODELS 46
  • 7.5 UROLOGICAL TUMOR MODELS 47
  • 7.6 HEMATOLOGICAL TUMOR MODELS 48
  • 7.7 OTHERS 49

8 ASIA-PACIFIC PDX MODELS MARKET, BY APPLICATION 50

  • 8.1 OVERVIEW 51
  • 8.2 PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH 53
  • 8.3 BIOMARKER ANALYSIS 54

9 ASIA-PACIFIC PDX MODELS MARKET, BY END USER 55

  • 9.1 OVERVIEW 56
  • 9.2 CONTRACT RESEARCH ORGANIZATIONS 58
  • 9.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 59
  • 9.4 ACADEMIC AND RESEARCH INSTITUTIONS 60

10 ASIA-PACIFIC PDX MODELS MARKET, BY GEOGRAPHY 61

  • 10.1 ASIA PACIFIC 61
    • 10.1.1 JAPAN 70
    • 10.1.2 CHINA 72
    • 10.1.3 INDIA 74
    • 10.1.4 SOUTH KOREA 76
    • 10.1.5 AUSTRALIA 78
    • 10.1.6 SINGAPORE 80
    • 10.1.7 THAILAND 82
    • 10.1.8 MALAYSIA 84
    • 10.1.9 INDONESIA 87
    • 10.1.10 PHILIPPINES 89
    • 10.1.11 REST OF ASIA PACIFIC 91

11 ASIA-PACIFIC PDX MODELS MARKET, COMPANY LANDSCAPE 92

  • 11.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 92

12 COMPANY PROFILES 93

  • 12.1 CHARLES RIVER 93
    • 12.1.1 COMPANY OVERVIEW 93
    • 12.1.2 REVENUE ANALYSIS 93
    • 12.1.3 COMPANY SHARE ANALYSIS 94
    • 12.1.4 PRODUCT PORTFOLIO 94
    • 12.1.5 RECENT DEVELOPMENTS 94
  • 12.2 CROWN BIOSCIENCE INC. (SUBSIDIARY OF JSR CORPORATION) 95
    • 12.2.1 COMPANY OVERVIEW 95
    • 12.2.2 GEOGRAPHIC PRESENCE 95
    • 12.2.3 COMPANY SHARE ANALYSIS 96
    • 12.2.4 PRODUCT PORTFOLIO 96
    • 12.2.5 RECENT DEVELOPMENTS 97
  • 12.3 CHAMPION ONCOLOGY, INC 98
    • 12.3.1 COMPANY OVERVIEW 98
    • 12.3.2 REVENUE ANALYSIS 98
    • 12.3.3 COMPANY SHARE ANALYSIS 99
    • 12.3.4 PRODUCT PORTFOLIO 99
    • 12.3.5 RECENT DEVELOPMENTS 99
  • 12.4 ARAGEN BIOSCIENCE (SUBSIDIARY OF GVK BIOSCIENCES PRIVATE LIMITED) 100
    • 12.4.1 COMPANY OVERVIEW 100
    • 12.4.2 PRODUCT PORTFOLIO 100
    • 12.4.3 RECENT DEVELOPMENTS 100
  • 12.5 CREATIVE ANIMODEL 101
    • 12.5.1 COMPANY OVERVIEW 101
    • 12.5.2 PRODUCT PORTFOLIO 101
    • 12.5.3 RECENT DEVELOPMENTS 101
  • 12.6 EPO BERLIN-BUCH GMBH 102
    • 12.6.1 COMPANY OVERVIEW 102
    • 12.6.2 PRODUCT PORTFOLIO 102
    • 12.6.3 RECENT DEVELOPMENTS 102
  • 12.7 EUROPDX 103
    • 12.7.1 COMPANY OVERVIEW 103
    • 12.7.2 GEOGRAPHICAL PRESENCE 103
    • 12.7.3 PRODUCT PORTFOLIO 104
    • 12.7.4 RECENT DEVELOPMENTS 104
  • 12.8 HERA BIOLABS 105
    • 12.8.1 COMPANY OVERVIEW 105
    • 12.8.2 PRODUCT PORTFOLIO 105
    • 12.8.3 RECENT DEVELOPMENTS 105
  • 12.9 HORIZON DISCOVERY GROUP PLC 106
    • 12.9.1 COMPANY OVERVIEW 106
    • 12.9.2 REVENUE ANALYSIS 106
    • 12.9.3 PRODUCT PORTFOLIO 107
    • 12.9.4 RECENT DEVELOPMENTS 107
  • 12.10 MI BIORESEARCH INC 108
    • 12.10.1 COMPANY OVERVIEW 108
    • 12.10.2 PRODUCT PORTFOLIO 108
    • 12.10.3 RECENT DEVELOPMENTS 108
  • 12.11 ONCODESIGN 109
    • 12.11.1 COMPANY OVERVIEW 109
    • 12.11.2 REVENUE ANALYSIS 109
    • 12.11.3 PRODUCT PORTFOLIO 110
    • 12.11.4 RECENT DEVELOPMENTS 110
  • 12.12 PHARMATEST SERVICES LTD 111
    • 12.12.1 COMPANY OVERVIEW 111
    • 12.12.2 GEOGRAPHIC PRESENCE 111
    • 12.12.3 PRODUCT PORTFOLIO 112
    • 12.12.4 RECENT DEVELOPMENTS 112
  • 12.13 THE JACKSON LABORATORY 113
    • 12.13.1 COMPANY OVERVIEW 113
    • 12.13.2 REVENUE ANALYSIS 113
    • 12.13.3 PRODUCT PORTFOLIO 114
    • 12.13.4 RECENT DEVELOPMENTS 114
  • 12.14 UROLEAD 115
    • 12.14.1 COMPANY OVERVIEW 115
    • 12.14.2 PRODUCT PORTFOLIO 115
    • 12.14.3 RECENT DEVELOPMENTS 115
  • 12.15 WUXI APPTEC 116
    • 12.15.1 COMPANY OVERVIEW 116
    • 12.15.2 GEOGRAPHIC PRESENCE 116
    • 12.15.3 PRODUCT PORTFOLIO 117
    • 12.15.4 RECENT DEVELOPMENTS 117
  • 12.16 XENTECH 118
    • 12.16.1 COMPANY OVERVIEW 118
    • 12.16.2 PRODUCT PORTFOLIO 118
    • 12.16.3 RECENT DEVELOPMENTS 118

13 RELATED REPORTS 119

LIST OF TABLES

  • TABLE 1 ASIA-PACIFIC PDX MODELS MARKET, BY TYPE, 2016- 2025, (USD MILLION) 38
  • TABLE 2 ASIA-PACIFIC MICE MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 39
  • TABLE 3 ASIA-PACIFIC RAT MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 40
  • TABLE 4 ASIA-PACIFIC PDX MODELS MARKET, BY TUMOR TYPE, 2016- 2025 (USD MILLION) 43
  • TABLE 5 ASIA-PACIFIC GASTROINTESTINAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 44
  • TABLE 6 ASIA-PACIFIC GYNECOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 45
  • TABLE 7 ASIA-PACIFIC RESPIRATORY TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 46
  • TABLE 8 ASIA-PACIFIC UROLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 47
  • TABLE 9 ASIA-PACIFIC HEMATOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 48
  • TABLE 10 ASIA-PACIFIC OTHERS TUMOR TYPES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 49
  • TABLE 11 ASIA-PACIFIC PDX MODELS MARKET, BY APPLICATION, 2016- 2025 (USD MILLION) 52
  • TABLE 12 ASIA-PACIFIC PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 53
  • TABLE 13 ASIA-PACIFIC BIOMARKER ANALYSIS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 54
  • TABLE 14 ASIA-PACIFIC PDX MODELS MARKET, BY END USER, 2016- 2025, (USD MILLION) 57
  • TABLE 15 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN PDX MODEL MARKET, BY REGION, 2016-2025, (USD MILLION) 58
  • TABLE 16 ASIA-PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION) 59
  • TABLE 17 ASIA-PACIFIC ACADEMIC AND RESEARCH INSTITUTIONS IN PDX MODELA MARKET, BY REGION, 2016-2025, (USD MILLION) 60
  • TABLE 18 ASIA PACIFIC PDX MODELS MARKET, BY COUNTRY , 2016 - 2025, (USD MILLION) 67
  • TABLE 19 ASIA PACIFIC PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 68
  • TABLE 20 ASIA PACIFIC PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 68
  • TABLE 21 ASIA PACIFIC PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 69
  • TABLE 22 ASIA PACIFIC PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 69
  • TABLE 23 JAPAN PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 70
  • TABLE 24 JAPAN PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 70
  • TABLE 25 JAPAN PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 71
  • TABLE 26 JAPAN PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 71
  • TABLE 27 CHINA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 72
  • TABLE 28 CHINA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 72
  • TABLE 29 CHINA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 73
  • TABLE 30 CHINA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 73
  • TABLE 31 INDIA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 74
  • TABLE 32 INDIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 74
  • TABLE 33 INDIA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 75
  • TABLE 34 INDIA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 75
  • TABLE 35 SOUTH KOREA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 76
  • TABLE 36 SOUTH KOREA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 76
  • TABLE 37 SOUTH KOREA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 77
  • TABLE 38 SOUTH KOREA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 77
  • TABLE 39 AUSTRALIA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 78
  • TABLE 40 AUSTRALIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 78
  • TABLE 41 AUSTRALIA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 79
  • TABLE 42 AUSTRALIA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 79
  • TABLE 43 SINGAPORE PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 80
  • TABLE 44 SINGAPORE PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 80
  • TABLE 45 SINGAPORE PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 81
  • TABLE 46 SINGAPORE PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 81
  • TABLE 47 THAILAND PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 82
  • TABLE 48 THAILAND PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 82
  • TABLE 49 THAILAND PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 83
  • TABLE 50 THAILAND PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 83
  • TABLE 51 MALAYSIA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 84
  • TABLE 52 MALAYSIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 85
  • TABLE 53 MALAYSIA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 85
  • TABLE 54 MALAYSIA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 86
  • TABLE 55 INDONESIA PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 87
  • TABLE 56 INDONESIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 87
  • TABLE 57 INDONESIA PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 88
  • TABLE 58 INDONESIA PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 88
  • TABLE 59 PHILIPPINES PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 89
  • TABLE 60 PHILIPPINES PDX MODELS MARKET, BY TUMOR TYPE, 2016 - 2025, (USD MILLION) 89
  • TABLE 61 PHILIPPINES PDX MODELS MARKET, BY APPLICATION, 2016 - 2025, (USD MILLION) 90
  • TABLE 62 PHILIPPINES PDX MODELS MARKET, BY END USER, 2016 - 2025, (USD MILLION) 90
  • TABLE 63 REST OF ASIA PACIFIC PDX MODELS MARKET, BY TYPE, 2016 - 2025, (USD MILLION) 91

LIST OF FIGURES

  • FIGURE 1 ASIA-PACIFIC PDX MODELS MARKET: SEGMENTATION 14
  • FIGURE 2 ASIA-PACIFIC PDX MODELS MARKET: DATA TRIANGULATION 17
  • FIGURE 3 ASIA-PACIFIC PDX MODELS MARKET: RESEARCH SNAPSHOT 18
  • FIGURE 4 ASIA-PACIFIC PDX MODELS MARKET : BOTTOM UP APPROACH 19
  • FIGURE 5 ASIA-PACIFIC PDX MODELS MARKET : TOP DOWN APPROACH 19
  • FIGURE 6 ASIA-PACIFIC PDX MODELS MARKET: INTERVIEW DEMOGRAPHICS 20
  • FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF PDX MODELS MARKET 23
  • FIGURE 8 BELOW MENTIONED IS R&D EXPENSE BY THE JACKSON LABORATORY FOR YEAR 2016-17: 25
  • FIGURE 9 ASIA-PACIFIC PDX MODELS MARKET: SEGMENTATION 32
  • FIGURE 10 RISING NUMBER OF PHARMACEUTICAL R&D ACTIVITIES IN CANCER RESEARCH AND RISING NEED FOR PERSONALIZED MEDICINE ARE EXPECTED TO DRIVE THE MARKET FOR PDX MODELS IN THE FORECAST PERIOD 2018 TO 2025 33
  • FIGURE 11 MICE MODELS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PDX MODELS MARKET IN 2018 & 2025 34
  • FIGURE 12 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR PDX MODELS MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 35
  • FIGURE 13 ASIA-PACIFIC PDX MODELS MARKET: BY TYPE, 2017 37
  • FIGURE 14 ASIA-PACIFIC PDX MODELS MARKET: BY TYUMOR TYPE, 2017 42
  • FIGURE 15 ASIA-PACIFIC PDX MODELS MARKET: BY APPLICATION, 2017 51
  • FIGURE 16 ASIA-PACIFIC PDX MODELS MARKET: BY END USER, 2017 56
  • FIGURE 17 ASIA PACIFIC PDX MODELS MARKET SNAPSHOT (2017) 61
  • FIGURE 18 ASIA PACIFIC PDX MODELS MARKET : BY COUNTRY (2017) 63
  • FIGURE 19 ASIA PACIFIC PDX MODELS MARKET : BY COUNTRY (2018 & 2025) 64
  • FIGURE 20 ASIA PACIFIC PDX MODELS MARKET: BY COUNTRY (2017 & 2025) 65
  • FIGURE 21 ASIA PACIFIC PDX MODELS MARKET : BY TYPE (2018-2025) 66
  • FIGURE 22 ASIA-PACIFIC PDX MODELS MARKET: COMPANY SHARE 2017 (%) 92
Back to Top